Winstead is proud to be a Bronze sponsor for the 2020 Texas Life Science Forum. Whether you are in the life science industry, launching a life science startup, seeking investment funding, affiliated with research and innovation at the life science academic institutions or simply curious about the life science space, this is an excellent opportunity to engage with the community. Spanning three days, you will hear keynotes, 35+ hand-picked life science and innovative healthcare ventures pitch with Q&A from expert VCs and investors, panel sessions and the TLSF Educational Symposium. Learn More Here.

What: Texas Life Science Forum, co-hosted by BioHouston and Rice Alliance
When: Tuesday, November 10-Thursday, November 12, 2020 
Where: Virtual – Link with Registration 
How much: Free, but registration required

Register Here.

Successful Raises and Investor Considerations

When it’s time to raise money (or invest in an early stage company) it’s important to understand how due diligence impacts a company’s valuation. In life science companies, initial due diligence can have a greater impact on early valuations than seen in other businesses and industries. This session will discuss what life science companies need to know to successfully go through a capital raise, including addressing the areas of due diligence with the greatest impact on valuation.

Moderator:

• Sarah Churchill Llamas, Shareholder and Chair of Healthcare Industry Group, Winstead PC

Panelists:

• Mark Chandler, Managing Director, Upstream Partners
• Aaron G.L. Fletcher, PhD, Managing Partner & Co-Founder, Bios Partners
• Jack Henneman, Director, Alafair Biosciences